Bruker set to bring chromatography-free diagnostics to the masses
23 Jun 2025
Jeff Zonderman, Vice President of Bruker Applied Mass Spectrometry, unveils major strides in clinical diagnostics with the acquisition of RECIPE, a leading provider of mass spectrometry diagnostic kits for small molecule analysis. Combined with Bruker’s DART (Direct Analysis in Real Time) technology, this move enables the development of fully integrated, chromatography-free mass spectrometry workflows tailored to clinical laboratories.
These innovations—centered around the EVOQ DART TQ+ system—promise higher throughput, reduced solvent use, and simplified workflows, making mass spectrometry more accessible to a wider range of labs. Clinical areas of focus include therapeutic drug monitoring, toxicology, and drugs of abuse, with Bruker working toward a future where mass spectrometry functions more like a traditional clinical analyzer.
With a proven track record in simplifying complex instrumentation—like the industry-leading MALDI Biotyper—Bruker is once again breaking down barriers to clinical adoption. By removing chromatography from the equation, the company is delivering greener, faster, and easier diagnostics for the real-world needs of today’s laboratories.
Watch to learn how Bruker is reshaping the future of clinical mass spectrometry.
About the company

Bruker Daltonics
Bruker Daltonics is dedicated to revolutionizing the field of molecular exploration. Our innovative solutions equip scientists with cutting-edge tools to delve deeper into the molecular realm and drive advancements in life sciences and biotechnology. Join us in our mission to push the boundaries of scientific discovery. The timsTOF series introduces the next generation of ion mobility technology. Trapped Ion Mobility Spectrometry (TIMS) adds an additional dimension of separation and delivers unprecedented specificity and sensitivity. The timsTOF Pro 2 with PASEF® technology delivers fast scanning speeds, making MS-based proteomics a reality, allowing the identification and quantification of thousands of proteins. The timsTOF SCP optimizes ion transfer with a new source geometry, expanding the horizons of single-cell proteomics and immunopeptidomics. The timsTOF fleX combines the power of MALDI technology with the added dimension of spatial resolution, enabling the groundbreaking field of SpatialOMx® on one platform. The MALDI-2 and microGRID options add unparalleled sensitivity and robustness for imaging experiments with cell-level resolution. With TIMS technology, the timsTOF series has unlocked a fourth dimension of analysis, enabling 4D-Proteomics™, 4D-Multiomics, and SpatialOMx®. From proteomics to metabolomics, lipidomics, and spatial omics, Bruker’s mass spectrometry solutions deliver breakthrough discoveries and deeper insights. With technology such as TIMS, smartbeam, scanning lasers for MALDI-MS Imaging, and eXtreme Resolution FTMS (XR) capable of revealing Isotopic Fine Structure (IFS) signatures, Bruker empowers scientists to drive innovation with precision.






